OKLAHOMA CITY, Dec. 30 /PRNewswire/ -- American Health Partners (http://www.ahpartners.com/), of Oklahoma City, has been chosen by ThyroTec, a New Jersey based medical products development company, to launch a presence in the market, establish brand equity, finalize product packaging, and develop and implement all sales and distribution functions for ThyroTest(TM), a new FDA approved, CLIA Waived rapid hypothyroid diagnostic screening device.
“American Health Partners recognizes the benefit of providing doctors a rapid screen for hypothyroidism. Millions of patients who needlessly suffer from the symptoms of hypothyroidism can be screened in one office visit and further steps for treatment can begin immediately,” said Brian Banks, president of American Health Partners. “American Health Partners brings medical innovations to life through a proprietary market readiness process and proven distribution management network. We look forward to partnering with ThyroTec on this outstanding medical innovation.”
Currently patients suffering from symptoms of hypothyroidism have to wait days to discover lab results. Because ThyroTest(TM) has also gained CLIA Waiver status, patients can now get test result for hypothyroidism in minutes, right in the doctor’s office.
“We are excited about bringing ThyroTest(TM) to the marketplace,” said Jim Small, president of ThyroTec, a New Jersey based medical products development company. “ThyroTest (TM) is the first, and only, product to receive FDA approval and CLIA waiver for identifying above normal levels of thyroid stimulating hormone (TSH) in a rapid format. This simple rapid diagnostic screen test is a qualitative measurement that allows physicians to screen patients for hypothyroidism in ten minutes with a whole blood sample.”
Hypothyroidism develops when the thyroid gland does not produce enough thyroid hormone, which regulates body’s metabolism. A lack of thyroid hormone affects many body systems. The incidence of hypothyroidism tends to increase with age, with older people, especially women, at highest risk.
Common symptoms include weight gain, fatigue, mood swings, weakness, dry and coarse skin and hair, hair loss, depression, decreased libido, trouble swallowing, increased cholesterol, heavy or irregular periods or trouble getting pregnant.
An estimated 13 million Americans live undiagnosed and needlessly suffer from hypothyroidism. It is also estimated that three to five percent of the U.S. population has some form of thyroid disease. Approximately one in every eight of American women will develop a thyroid disorder during her lifetime.
This release was issued on behalf of the above organization by Send2Press(TM), a unit of Neotrope(R). http://www.send2press.com/.
American Health Partners
CONTACT: Clay Bullard, Spokesman of American Health Partners, LLC,+1-405-949-0070, info@ahpartners.com
Web site: http://www.send2press.com/
Web site: http://www.ahpartners.com/